Advanced Biomed sells Hong Kong subsidiary for $23,000

Core Viewpoint - Advanced Biomed (ADVB) has agreed to sell its wholly owned subsidiary, Advanced Biomed Limited, for a total purchase price of $23,000, based on a valuation report [1] Group 1: Transaction Details - The sale involves 100% of the issued and outstanding shares of Advanced Biomed Limited, a Hong Kong company [1] - The transaction is subject to the terms and conditions outlined in the Agreement [1] - The closing of the transaction is set for December 23, with all intellectual property owned by the Hong Kong subsidiary being transferred to the buyer [1] Group 2: Intellectual Property Transfer - All intellectual property owned by Advanced Biomed Limited, including that of its wholly owned subsidiary Shanghai Sglcell Biotech, was included in the sale [1]